Bahl & Gaynor’s M.D.C. Holdings, Inc. MDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,509
Closed -$1.04M 344
2024
Q1
$1.04M Sell
16,509
-413,659
-96% -$25.3M 0.01% 245
2023
Q4
$23.8M Buy
430,168
+8,065
+2% +$357K 0.14% 94
2023
Q3
$17.4M Buy
422,103
+31,792
+8% +$1.48M 0.11% 108
2023
Q2
$18.3M Buy
390,311
+37,052
+10% +$1.54M 0.11% 102
2023
Q1
$13.7M Sell
353,259
-21,719
-6% -$803K 0.07% 108
2022
Q4
$11.8M Buy
374,978
+28,477
+8% +$880K 0.07% 111
2022
Q3
$9.5M Sell
346,501
-15,080
-4% -$499K 0.06% 118
2022
Q2
$11.7M Buy
361,581
+141,468
+64% +$5.06M 0.08% 103
2022
Q1
$8.33M Sell
220,113
-86,014
-28% -$3.93M 0.06% 122
2021
Q4
$17.1M Buy
306,127
+28,129
+10% +$1.43M 0.1% 93
2021
Q3
$13M Sell
277,998
-4
-0% -$203 0.08% 103
2021
Q2
$14.1M Sell
278,002
-10,526
-4% -$603K 0.09% 96
2021
Q1
$17.1M Buy
288,528
+3,715
+1% +$195K 0.11% 87
2020
Q4
$12.8M Buy
284,813
+28,055
+11% +$1.25M 0.08% 98
2020
Q3
$11.2M Buy
256,758
+31,854
+14% +$1.27M 0.08% 96
2020
Q2
$7.43M Buy
224,904
+13,187
+6% +$364K 0.06% 115
2020
Q1
$4.55M Buy
+211,717
New +$7.42M 0.04% 137

Other funds holding MDC

Bahl & Gaynor's MDC Position: Q2 2024 in Review

Bahl & Gaynor sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2024, closing a stake of 16,509 shares — an estimated $1.04M sold.

Bahl & Gaynor first reported a position in MDC in Q1 2020 and held it in 17 quarters. The position peaked at $23.8M in Q4 2023. 4 funds tracked by Wall St. Rank hold MDC as of Q2 2024.

  • Bahl & Gaynor reported no remaining M.D.C. Holdings, Inc. position as of Q2 2024 after selling out during the quarter.
  • Bahl & Gaynor sold 16,509 M.D.C. Holdings, Inc. shares in Q2 2024, an estimated $1.04M.
  • Bahl & Gaynor first reported a position in M.D.C. Holdings, Inc. in Q1 2020 and held it in 17 quarters.
  • Bahl & Gaynor's M.D.C. Holdings, Inc. position peaked at $23.8M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2024.

Based on Bahl & Gaynor's 13F filing for Q2 2024, filed 7 Aug 2024.